The Centers for Medicare and Medicaid Services (CMS) quietly announced it negotiated down 2027 prices for 15 drugs following negotiations between the agency and individual drugmakers.
The announcement concludes three rounds of direct negotiations between CMS and the drugmakers and represents the second annual cycle of negotiations conducted through the Medicare Drug
Free Trial
Register for free to keep reading.
To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.
- Unlimited access to industry insights
- Stay on top of key rules and regulatory changes with our Rules Navigator
- Ad-free experience with no distractions
- Regular podcasts from trusted external experts
- Fresh compliance and regulatory content every day
